Kentucky lawmakers have officially overridden Democratic Governor Andy Beshear’s veto of legislation that seeks to provide legal protections for Bayer, a global agrochemical company. This law aims to shield Bayer from state-level lawsuits concerning allegations that its widely used Roundup weedkiller could be linked to cancer.
### Legislative Action and Veto Override
The veto override, executed by the Republican-majority General Assembly on Wednesday, arrives shortly before a pivotal U.S. Supreme Court hearing on a case that may establish broader legal protections against liability claims related to glyphosate—the active ingredient in Roundup. In addition, Bayer is currently seeking approval for a $7.25 billion settlement in Missouri intended to resolve numerous claims asserting that Roundup has caused non-Hodgkin lymphoma in users.
This legislative action highlights the increasing focus on Bayer’s financial challenges amid growing legal pressures and demonstrates a stark divide in opinion regarding agricultural regulation and public health.
### The Roundup Controversy
Roundup was introduced by Monsanto in 1974 and has since become a staple in agricultural practices, often used in conjunction with genetically modified seeds designed to withstand the herbicide’s effects. Bayer acquired Monsanto in 2018, inheriting a significant number of lawsuits—approximately 200,000—claiming that glyphosate is a carcinogen.
While Bayer disputes these allegations, the associated legal costs have been reported to threaten the company’s market position in glyphosate-based products. In response, Bayer has already phased out glyphosate from its residential product line.
Despite some studies suggesting a potential link between glyphosate and cancer, the U.S. Environmental Protection Agency (EPA) has classified the chemical as unlikely to pose a cancer risk to humans when used according to guidelines. Importantly, the federally mandated labeling for Roundup contains no cancer-related warnings.
### State Legislation and Future Implications
Central to the controversy is the assertion that Bayer and its affiliated brands have not adequately warned consumers about the potential risks associated with Roundup. In an effort to counteract this narrative, Bayer has allied with agricultural organizations, collectively known as the Modern Ag Alliance. This coalition has supported similar legal measures across various states, arguing that federal pesticide labels should suffice to meet state legal obligations regarding warning consumers.
The Kentucky law represents a continuation of a trend initiated in North Dakota and Georgia, where similar protections were enacted last year. Following the override of Governor Beshear’s veto, Kentucky joins this list, further solidifying the legal framework that supports such exemptions for agribusiness.
Elizabeth Burns-Thompson, the executive director of Modern Ag Alliance, lauded the Kentucky legislation for bringing “clear, consistent rules” that would benefit farmers and bolster agricultural operations.
Governor Beshear, a former attorney general, criticized the legislation in his veto message, asserting that it would permit hazardous pesticides to be sold without appropriate hazard warnings. He pointed out that many consumer products, including cosmetics and household cleaners, routinely carry warning labels to inform the public of potential risks.
### Upcoming Supreme Court Hearing
The Supreme Court is scheduled to hear arguments on April 27 regarding a Missouri case, wherein a jury previously awarded $1.25 million to an individual who developed non-Hodgkin lymphoma attributed to Roundup exposure. The jury found Monsanto liable for not sufficiently warning users about associated risks.
Bayer contends that federal pesticide laws should preempt state-level failure-to-warn lawsuits, asserting that state regulations cannot require more stringent labeling practices than those mandated at the federal level. This assertion has garnered contrasting responses from various stakeholders, including agricultural advocacy groups, healthcare organizations, and legal experts.
Some former EPA officials have filed briefs arguing against Bayer’s position, emphasizing that the absence of a cancer warning on pesticide labels should not eliminate the possibility of state-level lawsuits. They contend that the manufacturer’s failure to propose such a warning reflects a need for accountability.
### Proposed Settlement Context
Simultaneously, Bayer is navigating a proposed settlement aimed at resolving both current and future litigation claims linked to Roundup. A St. Louis Circuit Court judge has granted preliminary approval for a deal that may require Bayer to contribute funds annually for a period of up to 21 years, totaling as much as $7.25 billion. Payments would vary based on usage of Roundup, age at diagnosis, and severity of the illness, with an average payout of $165,000 for those diagnosed under age 60 with aggressive non-Hodgkin lymphoma.
This settlement would mitigate some of the financial risk associated with potential Supreme Court rulings, ensuring that plaintiffs could receive compensation regardless of the court’s decision. Simultaneously, it would protect Bayer against the possibility of incurring heavier liabilities if the ruling were unfavorable.
As these developments unfold, they signify a critical intersection of agricultural policy, public health considerations, and corporate accountability in the ongoing discourse surrounding glyphosate and its implications for consumers.
Source: Original Reporting
About The Author
